What is Hydromorphone? 1
- Semi-synthetic opioid analgesic derived from morphine.
- Used for the management of moderate to severe pain.
Mechanism of Action & Pharmacokinetics 12
- Primarily acts on mu-opioid receptors in the central nervous system (CNS) to produce analgesia.
- Onset in 30-60 minutes (PO) and 10-15 minutes (IV), half life 2-3 hours 3
- Binds to opioid receptors leading to inhibition of ascending pain pathways, altering the perception of and response to pain.
- Metabolized in the liver by glucuronidation, producing dihydromorphine and dihydroisomorphine (active) and hydromorphone-3-glucuronide (inactive)
- hydromorphone-3-glucuronide can accumulate in renal failure which can cause cognitive effects and neuroexcitation 2
- Excreted primarily through the kidneys.
Pharmacodynamics 12
Cardiovascular
- Can cause mild to moderate hypotension due to peripheral vasodilation.
- Minimal effects on myocardial contractility, but may cause bradycardia in some patients.
Respiratory
- Depresses respiratory centers in the brainstem, leading to decreased respiratory rate and minute ventilation. Often compensatory increased tidal volume occurs 1
- Risk of respiratory depression increases with dose and concomitant use of other CNS depressants.
Indications 1
- Management of moderate to severe pain where the use of an opioid analgesic is appropriate.
- Often used in postoperative pain management, cancer pain, and severe acute pain.
Dosage 2
- Oral:
- 2 to 4 mg every 4 to 6 hours as needed for pain.
- Intravenous (IV):
- 0.2 to 1 mg every 2 to 3 hours as needed for pain.
- 5-15 mcg/kg in pediatrics
- Patient-Controlled Analgesia (PCA):
- Initial demand dose: 0.1 to 0.2 mg IV; lockout interval typically 6 to 10 minutes.
- Dosage should be adjusted based on the patient's response, tolerance, and severity of pain.
Contraindications 12
- Hypersensitivity to hydromorphone or any of its components.
- Severe respiratory depression without resuscitative equipment or monitoring.
Complications 124
- Respiratory depression, which can be severe and life-threatening, especially in opioid-naive patients.
- Common opioid-related side effects include nausea, vomiting, constipation, pruritus, and sedation.
- Long-term use may lead to tolerance, physical dependence, and opioid use disorder.
- Risk of hypotension, especially in patients with compromised blood pressure or on concomitant medications that lower blood pressure.
References
-
Birdi T, Sullivan P. Ottawa Anesthesia Primer. Toronto, Ontario: Echo Book Publishing; 2012. ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7
-
@cullenBarashCullenStoelting2024 Bruce F. Cullen, Bruce F. Cullen, Barash, Cullen, and Stoelting's clinical anesthesia, 2024 Private or Broken Links
The page you're looking for is either not available or private!
-
@pardo2017basics M. Pardo, R.D. Miller, Basics of anesthesia E-book, 2017 Private or Broken Links
The page you're looking for is either not available or private!
-
Ducharme, S. (2020). Hydromorphone. Anesthesia & Analgesia, 91(5): 1224-1226. DOI: 10.1097/00000539-202005000-00034. ↩